{{Drugbox
| verifiedrevid = 443649688
| IUPAC_name = 5,6-bis(4-methoxyphenyl)-3-methyl-1,2,4-triazine
| image = Anitrazafen structure.png
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number = 63119-27-7
| ATC_prefix = none
| PubChem = 44410
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL = 2105947
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 40409
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2Y065P7MYR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02948
| synonyms =  
<!--Chemical data-->
| C=18 | H=17
| N=3 | O=2
| molecular_weight = 307.35 g/mol
| smiles = n2c(nnc(c1ccc(OC)cc1)c2c3ccc(OC)cc3)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H17N3O2/c1-12-19-17(13-4-8-15(22-2)9-5-13)18(21-20-12)14-6-10-16(23-3)11-7-14/h4-11H,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HDNJXZZJFPCFHG-UHFFFAOYSA-N
}}

Anitrazifen is a drug displaying [[COX-2 inhibitor]] activity.

{{Anti-inflammatory and antirheumatic products}}
{{Analgesics}}
{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:COX-2 inhibitors]]
[[Category:Triazines]]
[[Category:Phenol ethers]]


{{musculoskeletal-drug-stub}}